Clinical Trial Update: Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating CBP501 in combination with pemetrexed and cisplatin for malignant pleural mesothelioma; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma
• Solid Tumors

Drugs mentioned

• CBP501
• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: CanBas Co. Ltd. | Conditions: Malignant Pleural Mesothelioma, Solid Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-07-20